Literature DB >> 15850440

Bisphosphonates and osteonecrosis of the jaw.

Patrick M Purcell1, Ian W Boyd.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15850440     DOI: 10.5694/j.1326-5377.2005.tb06762.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  29 in total

1.  Practical guidelines for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in patients with cancer.

Authors:  Salvatore Ruggiero; Julie Gralow; Robert E Marx; Ana O Hoff; Mark M Schubert; Joseph M Huryn; Bela Toth; Kathryn Damato; Vicente Valero
Journal:  J Oncol Pract       Date:  2006-01       Impact factor: 3.840

Review 2.  Bisphosphonate-related osteonecrosis of the jaw in non-malignant bone disease.

Authors:  Peter K Wong; Gelsomina L Borromeo; John D Wark
Journal:  Rheumatol Int       Date:  2013-05-08       Impact factor: 2.631

3.  [Necrosis of the jaws under bisphosphonate therapy].

Authors:  S Hoefert; H Eufinger
Journal:  Orthopade       Date:  2006-02       Impact factor: 1.087

Review 4.  Skeletal complications of breast cancer therapies.

Authors:  Angela Hirbe; Elizabeth A Morgan; Ozge Uluçkan; Katherine Weilbaecher
Journal:  Clin Cancer Res       Date:  2006-10-15       Impact factor: 12.531

Review 5.  HIF targets in bone remodeling and metastatic disease.

Authors:  Rachelle W Johnson; Ernestina Schipani; Amato J Giaccia
Journal:  Pharmacol Ther       Date:  2015-02-12       Impact factor: 12.310

Review 6.  Bone-Fat Interaction.

Authors:  Elizabeth Rendina-Ruedy; Clifford J Rosen
Journal:  Endocrinol Metab Clin North Am       Date:  2016-11-24       Impact factor: 4.741

Review 7.  Bisphosphonates in multiple myeloma: an updated network meta-analysis.

Authors:  Rahul Mhaskar; Ambuj Kumar; Branko Miladinovic; Benjamin Djulbegovic
Journal:  Cochrane Database Syst Rev       Date:  2017-12-18

8.  Jaw osteonecrosis associated with use of bisphosphonates and chemotherapy: paradoxical complication of treatment of bone lesions in multiple myeloma patients.

Authors:  Silvana Capalbo; Mario Delia; Daniela Diomede; Michelina Dargenio; Antonia Chiefa; Gianfranco Favia; Vincenzo Liso
Journal:  Int J Hematol       Date:  2006-06       Impact factor: 2.490

Review 9.  Bisphosphonate-induced osteonecrosis of the jaws: review, clinical implications and case report.

Authors:  Yusuf Farouk Suleman; Shabnum Meer; Russel Lurie
Journal:  Head Neck Pathol       Date:  2007-12-08

10.  Osteonecrosis of the jaw induced by orally administered bisphosphonates: incidence, clinical features, predisposing factors and treatment outcome.

Authors:  N Yarom; R Yahalom; Y Shoshani; W Hamed; E Regev; S Elad
Journal:  Osteoporos Int       Date:  2007-06-28       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.